Britain goes it alone over coronavirus. We can only hope the gamble pays off | Devi Sridhar
posted 17 hours
Mashup Score: 525
The Guardian - Ignoring advice and lessons from Europe and Asia on mass testing and isolation, health experts insist that our approach is the...
What a recent Covid-19 flight outbreak tells us about spread on planes
posted 1 day
Mashup Score: 502
Vox - “Is flying safe?” is the wrong...
“... flights can be anywhere from safe to unsafe depending on a number of factors. It’s also an example of why viral transmission is not so much a single event, but the result of multiple lapses in safety.” @AbraarKaran https://t.co/m5ZrLzzbZZ
Study: Patients Hospitalized With COVID-19 Have Low Levels of 25-Hydroxyvitamin D
posted 2 days
Mashup Score: 460
Pharmacy Times - One of the more recent potential risk factors of COVID-19 is vitamin D deficiency, which is an important modulator of innate and acquired...
Study: Patients Hospitalized With COVID-19 Have Low Levels of 25-Hydroxyvitamin D Learn more: https://t.co/N6TFKn28p2 https://t.co/N6TFKn28p2
Eli Lilly and Company - The Investor Relations website contains information about Eli Lilly and Company’s business for stockholders, potential investors, and financial...
1st Phase 3 trial results on #SARSCoV2 monoclonal antibody combination with very positive results 1035 patients: 11 (2%) v (7%) for death or hospitalization and 0 vs 10 deaths in high-risk patients, given early https://t.co/BXnwCd64O9 (press release). Coincides w/ EUA criteria. https://t.co/BXnwCd64O9
WPXI - With the uncertainty on the availability of the COVID-19 vaccine, the question of ‘What happens if the second dose is delayed?’ has come...
In this @GabriellaDeLuca @WPXI TV interview I discuss 2nd #COVID19 vaccine doses. You don’t have to start the series over if you receive it late and you’ll still get the same benefit post-2nd dose https://t.co/omk7EVHaRl
Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says
posted 20 hours
Mashup Score: 288
Reuters Health - French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the...
This is the kind of good news I have been waiting to see. https://t.co/CuXbTwoLw0
Great! https://t.co/jQJZ1TfyOL
Moderna, Inc. - Out of an abundance of caution, Moderna launches clinical program to boost immunity to emerging variants Manuscript posted to preprint server; company to host...
I'll try to do a Tweetorial tonight about what the Moderna data means for the current vaccines. Maybe the preprint is out by then. https://t.co/Xlcpq4HUzX
In a major setback, Merck to stop developing its Covid-19 vaccines – STAT
posted 2 days
Mashup Score: 254
STAT - Merck announced it is stopping development of both of the current formulations of the Covid-19 vaccines the company was working...
In a major setback, Merck to stop developing its Covid-19 vaccines - STAT “. . . a reminder that developing new vaccines is difficult, and that the world is lucky that the first two — the Moderna and Pfizer/BioNTech shots — were so effective.” https://t.co/Flyhdm59mf
Overcrowded and overwhelmed: Why Israel’s current COVID-19 wave is the ‘worst yet’
posted 23 hours
Mashup Score: 248
haaretz.com - ...
Israel has been lauded for vaccinating over one quarter of its population already. Yet they are seeing the worst wave of COVID-19 yet and can’t figure out why. This should at least raise concerns about the vaccine. https://t.co/THV31WjOta
A year into pandemic, with no cure in sight, ICU doctors take COVID-19 one day at a time
posted 2 days
Mashup Score: 184
MPR News - In a year marked by tragedy and heartbreak, health care providers have been able to study COVID-19 in real time and figure out ways...
In this @catrichert @MPRnews piece I'm quoted about multiple aspects of how critical care of #COVID19 patients has improved throughout the pandemic https://t.co/NdE2sXWhOf
Wrote this 10 months ago. Britain's gamble failed. https://t.co/02FJz7JCkI